![Hugo Thomas Torquil Mackenzie-Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hugo Thomas Torquil Mackenzie-Smith
Direktor/Vorstandsmitglied bei Ellenborough Park Hotel
Aktive Positionen von Hugo Thomas Torquil Mackenzie-Smith
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ellenborough Park Hotel
![]() Ellenborough Park Hotel Hotels/Resorts/Cruise linesConsumer Services Part of Shetland Business Ltd., Ellenborough Park Hotel is a luxury 5-star hotel located in Cheltenham, UK. In addition to its luxurious accommodations, Ellenborough Park Hotel also offers exciting activities such as husky driving and archery to showcase the best of the Cotswolds. Founded in 2008, the hotel offers a uniquely charming corporate meeting event venue, spa, and a range of dining options including alfresco dining. | Direktor/Vorstandsmitglied | 17.01.2012 | - |
Immodulon Therapeutics Ltd.
![]() Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Direktor/Vorstandsmitglied | 01.01.2009 | - |
Karriereverlauf von Hugo Thomas Torquil Mackenzie-Smith
Statistik
International
Vereinigtes Königreich | 3 |
Operativ
Director/Board Member | 2 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Immodulon Therapeutics Ltd.
![]() Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Health Technology |
Ellenborough Park Hotel
![]() Ellenborough Park Hotel Hotels/Resorts/Cruise linesConsumer Services Part of Shetland Business Ltd., Ellenborough Park Hotel is a luxury 5-star hotel located in Cheltenham, UK. In addition to its luxurious accommodations, Ellenborough Park Hotel also offers exciting activities such as husky driving and archery to showcase the best of the Cotswolds. Founded in 2008, the hotel offers a uniquely charming corporate meeting event venue, spa, and a range of dining options including alfresco dining. | Consumer Services |